ID: ALA4750706

Max Phase: Preclinical

Molecular Formula: C28H37N9O8S

Molecular Weight: 659.73

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  N=C(N)Nc1cc(NC(=O)CCCN)cc(C(=O)NCC(=O)NC[C@H](NC(=O)[C@@H]2CCCN2S(=O)(=O)c2ccccc2)C(=O)O)c1

Standard InChI:  InChI=1S/C28H37N9O8S/c29-10-4-9-23(38)34-18-12-17(13-19(14-18)35-28(30)31)25(40)33-16-24(39)32-15-21(27(42)43)36-26(41)22-8-5-11-37(22)46(44,45)20-6-2-1-3-7-20/h1-3,6-7,12-14,21-22H,4-5,8-11,15-16,29H2,(H,32,39)(H,33,40)(H,34,38)(H,36,41)(H,42,43)(H4,30,31,35)/t21-,22-/m0/s1

Standard InChI Key:  MGRPJUCLIBBWKX-VXKWHMMOSA-N

Associated Targets(Human)

Integrin alpha-5/beta-1 686 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Integrin alpha-V/beta-1 222 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Integrin alpha-V/beta-3 2708 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 659.73Molecular Weight (Monoisotopic): 659.2486AlogP: -1.06#Rotatable Bonds: 15
Polar Surface Area: 279.00Molecular Species: ZWITTERIONHBA: 9HBD: 9
#RO5 Violations: 2HBA (Lipinski): 17HBD (Lipinski): 11#RO5 Violations (Lipinski): 3
CX Acidic pKa: 3.04CX Basic pKa: 10.03CX LogP: -4.62CX LogD: -5.88
Aromatic Rings: 2Heavy Atoms: 46QED Weighted: 0.08Np Likeness Score: -1.19

References

1. Sundaram A,Chen C,Isik Reed N,Liu S,Ki Yeon S,McIntosh J,Tang YZ,Yang H,Adler M,Beresis R,Seiple IB,Sheppard D,DeGrado WF,Jo H.  (2020)  Dual antagonists of α5β1/αvβ1 integrin for airway hyperresponsiveness.,  30  (22): [PMID:33007395] [10.1016/j.bmcl.2020.127578]

Source